Page last updated: 2024-10-27

flurbiprofen and Peptic Ulcer

flurbiprofen has been researched along with Peptic Ulcer in 3 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Peptic Ulcer: Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).

Research Excerpts

ExcerptRelevanceReference
"Flurbiprofen-treated rats showed severe gastrointestinal ulcerations (bleeding in 3/8 rats) and nefrotoxicity, which was not observed in nitroflurbiprofen-treated cirrhotic rats."1.34Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. ( Fevery, J; Laleman, W; Nevens, F; Van der Elst, I; Van Landeghem, L; Zeegers, M, 2007)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laleman, W1
Van Landeghem, L1
Van der Elst, I1
Zeegers, M1
Fevery, J1
Nevens, F1
McCracken, JD1
Wechter, WJ1
Liu, Y1
Chase, RL1
Kantoci, D1
Murray, ED1
Quiggle, DD1
Mineyama, Y1
Mahmud, T1
Somasundaram, S1
Sigthorsson, G1
Simpson, RJ1
Rafi, S1
Foster, R1
Tavares, IA1
Roseth, A1
Hutt, AJ1
Jacob, M1
Pacy, J1
Scott, DL1
Wrigglesworth, JM1
Bjarnason, I1

Other Studies

3 other studies available for flurbiprofen and Peptic Ulcer

ArticleYear
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Gastroenterology, 2007, Volume: 132, Issue:2

    Topics: Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Endoth

2007
Antiproliferative effects of the enantiomers of flurbiprofen.
    Journal of clinical pharmacology, 1996, Volume: 36, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Cyclooxygenase Inhibitors; Female;

1996
Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat.
    Gut, 1998, Volume: 43, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Proteins; Cyclooxygenase Inhibit

1998